Transforming Temperature Data Management Practices to Reduce Labour Costs and Improve Visibility and Control

Dec 17, 2014

Central to the good distribution practices of a biopharma company is the reliability and traceability of temperature data associated with temperature-sensitive shipments. There are a number of temperature-monitoring database options available to improve workflow which will reduce administrative time. Patrick McGrath of Berlinger provides insight into practices for improving common processes through enhanced database functionality in the areas of managing data loggers by expiry date, storing and retrieving calibration certificates and acknowledging/documenting common temperature excursion events. ...

Read More

Securing the Global Pharmaceutical Supply Chain Against the Threat of Counterfeit Drugs

Dec 17, 2014

According to the WHO, the prevalence of spurious, falsely-labelled, falsified, or counterfeit medicines, or SFFC medicines as they are known − medicines that are deliberately and fraudulently produced, packaged and/or mislabelled − is a growing trend worldwide which threatens both patient safety and public confidence in the health systems and regulatory bodies designed to provide oversight and control. Dr Rudiger Lomb of World Courier tells us what pharmaceutical professionals can do to ensure that their organisations and the patients they serve are not impacted by counterfeit drugs. ...

Read More

Logistics: The Power of Clinical Trial Supply Visibility

Dec 17, 2014

As a result of the globalisation of clinical trials, one of the biggest challenges that pharmaceutical companies face is the management of the clinical trial supply chain. This work is increasingly outsourced to specialised clinical trial services companies, who become key partners in helping the pharmaceutical company efficiently navigate the clinical supply chain. Claudia Williams and Rishi Saini of Biotec-PCI address the specific features that an online reporting system should provide in order to maximise the visibility and efficiency of the clinical supply chain. ...

Read More

Advocating an Integrated Approach to the Global Diabetes Epidemic

Dec 17, 2014

The non-communicable disease of diabetes has reached epidemic proportions, and it knows no geographic boundaries. It`s time to take a sombre look at the consequences of letting the worldwide diabetes epidemic continue to progress, and decide how we, as a globally unified body of health professionals and health agencies, wish to proceed, points out Dr J. Rick Turner of Quintiles. He advocates for the adoption of an integrated approach to addressing the global diabetes epidemic, because it offers the most promise for the prevention of future cases of diabetes, and for the treatment of patients who currently have diabetes. ...

Read More

Opportunities for Monoclonal Antibodies in Bacterial Infectious Diseases

Dec 17, 2014

The management of infectious disease is challenged by trends that impact patient welfare on a global scale; the emergence of multi-drug-resistant (MDR) forms of new and old bacterial pathogens, the world’s increasing population of immunocompromised patients where antimicrobial therapy is less effective, and fewer new antibiotics being licensed. If these trends continue, the dreaded “post-antibiotic era” could become a reality. Fraser Leslie of Arsanis discusses the vast potential of monoclonals for combating antibiotic resistance with many anti-infectious mAbs currently in development. ...

Read More